News
-
-
PRESS RELEASE
ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium
ProteinQure to present promising data on PQ203, a peptide drug conjugate for TNBC treatment, at 2024 San Antonio Breast Cancer Symposium. Phase 1 trial in 2025 -
-
-
-
-
-
-
-
PRESS RELEASE
New to the Street Episode 614 Premieres on Bloomberg: Featuring Banzai, HPB, PillSafe, the Sustainable Green Team, Sekur Private Data Ltd., and PetVivo Holdings, Inc. - Friday, December 6th at 9:30 PM PST
New to The Street announces premiere of Episode 614 on Bloomberg Television featuring innovative companies like Banzai, HPB, PillSafe, SGTM, Sekur Private Data Ltd., and PetVivo Holdings